For three decades, the Santa Monica firm has worked behind the scenes where science, logistics and pharmaceutical compliance collide. Its real product is not the meeting, the slide deck or the app - it is making all three agree.
Drug makers can design a promising study and still lose years waiting for the right people to enroll. Conquest Research built a local, patient-facing machine to make that slow middle move faster - then took it across three states.
Dan Rubin is President and CEO of PARx Solutions, a Burlington, Massachusetts healthtech company that runs the Prior Authorization Support System (PASS), a service that helps physician offices push prescriptions past insurer prior-authorization roadblocks at no cost to the practice. A chemical engineer by training who switched to building businesses, Rubin co-founded medication-adherence pioneer Adheris in 1993, ran it for fifteen years, then took the helm at PARx in 2012. He has spent three decades on a single problem: the gap between a doctor writing a prescription and a patient actually getting the medicine.